Pictet Asset Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.6M Buy
492,068
+388,523
+375% +$44M 0.06% 285
2026
Q1
$11.2M Sell
103,545
-20,904
-17% -$2.47M 0.01% 630
2025
Q4
$16.8M Sell
124,449
-72,387
-37% -$7.9M 0.02% 564
2025
Q3
$16.7M Buy
+196,836
New +$12.1M 0.02% 561

Other funds holding ABVX

Pictet Asset Management's ABVX Position: Q2 2026 in Review

Pictet Asset Management increased its Abivax (ABVX) stake by 375% in Q2 2026, buying an estimated $44M and bringing the position to 492,068 shares worth $65.6M. The position accounts for 0.06% of the portfolio, ranked #285.

Pictet Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Pictet Asset Management held 492,068 shares of Abivax worth $65.6M as of Q2 2026.
  • Pictet Asset Management bought 388,523 Abivax shares in Q2 2026, an estimated $44M.
  • Abivax made up 0.06% of Pictet Asset Management's portfolio in Q2 2026, its #285 holding.
  • Pictet Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.